Guided Therapeutics, Inc.

The company is a medical technology company that develops innovative medical devices. Its primary focus is the sales and marketing of its LuViva® Advanced Cervical Scan, a non-invasive device for detecting cervical cancer. LuViva uses biophotonics technology to identify cervical cancers and precancers by scanning the cervix with light and analyzing the reflected and fluorescent light. This device is designed to be a less invasive, painless, and convenient alternative to conventional tests, providing rapid results at the point of care. The company targets two main applications for LuViva. First, it serves as a cancer screening tool in the developing world, where infrastructure for traditional screening methods is limited or absent. Second, in the developed world, it functions as a triage following traditional screening to address the high rate of unnecessary and costly follow-up tests caused by false positive results. Cervical cancer screening is a significant area of diagnostic medicine, with approximately 2.0 billion women aged 15 and older in the developing world potentially eligible for screening with LuViva. Traditional Pap smear tests, while primary in the developed world, are expensive and require infrastructure and skills often lacking in developing countries.